Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 79626 - 79650 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tianeptine	Investigational	SREBF1	6720	upregulated	tianeptine results in increased expression of SREBF1 mRNA	17p11.2	A20645
Ticlopidine	Approved	HMOX1	3162	upregulated	Ticlopidine results in increased expression of HMOX1 mRNA	22q12.3	A21482
Ticlopidine	Approved	UGT1A1	54658	upregulated	Ticlopidine results in increased expression of UGT1A1 mRNA	2q37.1	A21482
Tienilic acid	Approved Withdrawn	HMOX1	3162	upregulated	Ticrynafen results in increased expression of HMOX1 mRNA	22q12.3	A21482
Tienilic acid	Approved Withdrawn	UGT1A1	54658	upregulated	Ticrynafen results in increased expression of UGT1A1 mRNA	2q37.1	A21482
Tiopronin	Approved	ABCB1	5243	downregulated	Tiopronin results in decreased stability of and results in decreased expression of ABCB1 mRNA	7q21.12	A24431
Titanium dioxide	Approved	ADORA2A	135	downregulated	titanium dioxide results in decreased expression of ADORA2A mRNA	22q11.23	A24217
Titanium dioxide	Approved	ALDH1A1	216	downregulated	[Vitallium analog binds to titanium dioxide] which results in decreased expression of ALDH1A1 mRNA	9q21.13	A24432
Titanium dioxide	Approved	ALPL	249	upregulated	titanium dioxide results in increased expression of ALPL mRNA	1p36.12	A20622
Titanium dioxide	Approved	BARD1	580	downregulated	[Vitallium analog binds to titanium dioxide] which results in decreased expression of BARD1 mRNA	2q35	A24432
Titanium dioxide	Approved	BAX	581	upregulated	titanium dioxide results in increased expression of BAX mRNA	19q13.33	A24433
Titanium dioxide	Approved	BCAN	63827	upregulated	titanium dioxide results in increased expression of BCAN mRNA	1q23.1	A24434
Titanium dioxide	Approved	BCL2	596	downregulated	titanium dioxide results in decreased expression of BCL2 mRNA	18q21.33	A24433 A24435
Titanium dioxide	Approved	BCL2L1	598	downregulated	titanium dioxide results in decreased expression of BCL2L1 mRNA	20q11.21	A24433
Titanium dioxide	Approved	BIRC5	332	downregulated	[Vitallium analog binds to titanium dioxide] which results in decreased expression of BIRC5 mRNA	17q25.3	A24432
Titanium dioxide	Approved	BMP2	650	downregulated	[Vitallium analog binds to titanium dioxide] which results in decreased expression of BMP2 mRNA	20p12.3	A24432
Titanium dioxide	Approved	C5	727	upregulated	titanium dioxide results in increased expression of C5 mRNA	9q33.2	A24434 A24217
Titanium dioxide	Approved	CASP3	836	upregulated	titanium dioxide results in increased expression of CASP3 mRNA	4q35.1	A24436
Titanium dioxide	Approved	CCL2	6347	upregulated	titanium dioxide results in increased expression of CCL2 mRNA	17q12	A24434 A24217
Titanium dioxide	Approved	CCL4	6351	upregulated	titanium dioxide results in increased expression of CCL4 mRNA	17q12	A24434
Titanium dioxide	Approved	CCL5	6352	upregulated	titanium dioxide results in increased expression of CCL5 mRNA	17q12	A24434
Titanium dioxide	Approved	CCNA2	890	downregulated	[Vitallium analog binds to titanium dioxide] which results in decreased expression of CCNA2 mRNA	4q27	A24432
Titanium dioxide	Approved	CCNB2	9133	downregulated	[Vitallium analog binds to titanium dioxide] which results in decreased expression of CCNB2 mRNA	15q22.2	A24432
Titanium dioxide	Approved	CCND1	595	downregulated	[Vitallium analog binds to titanium dioxide] which results in decreased expression of CCND1 mRNA	11q13.3	A24432
Titanium dioxide	Approved	CCNE1	898	downregulated	[Vitallium analog binds to titanium dioxide] which results in decreased expression of CCNE1 mRNA	19q12	A24432

Displaying entries 79626 - 79650 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability